pharma

Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds

by

The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.

From Sludge
On July 13, 2021

Koch Group Fights Drug Price Reforms After Taking Big Pharma Money

by

Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.

From Sludge
On May 6, 2021